3/27
11:00 am
sny
Sanofi gains EU approval recommendation for Scarlisa subcutaneous version [Seeking Alpha]
Low
Report
Sanofi gains EU approval recommendation for Scarlisa subcutaneous version [Seeking Alpha]
3/27
10:13 am
sny
AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed [MSNBC.com]
Low
Report
AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed [MSNBC.com]
3/27
09:44 am
sny
EU regulator backs Sanofi's injectable version of blood cancer drug [Yahoo! Finance]
Low
Report
EU regulator backs Sanofi's injectable version of blood cancer drug [Yahoo! Finance]
3/27
08:54 am
sny
AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed [CNBC]
Neutral
Report
AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed [CNBC]
3/27
08:47 am
sny
Novo's FDA voucher victory; biotech's rigid glass ceiling [Yahoo! Finance]
Low
Report
Novo's FDA voucher victory; biotech's rigid glass ceiling [Yahoo! Finance]
3/27
08:00 am
sny
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
Low
Report
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
3/24
06:08 pm
sny
Sanofi (SNY) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d+)".
Low
Report
Sanofi (SNY) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d+)".
3/24
04:29 pm
sny
Sanofi Autoimmune Pipeline Grows As Market Weighs Valuation And Momentum [Yahoo! Finance]
Low
Report
Sanofi Autoimmune Pipeline Grows As Market Weighs Valuation And Momentum [Yahoo! Finance]
3/24
06:43 am
sny
Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody [Yahoo! Finance]
Low
Report
Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody [Yahoo! Finance]
3/24
03:08 am
sny
Press release: Availability of the Q1 2026 aide-mémoire [Yahoo! Finance]
Low
Report
Press release: Availability of the Q1 2026 aide-mémoire [Yahoo! Finance]
3/24
02:30 am
sny
Press release: Availability of the Q1 2026 aide-mémoire
Low
Report
Press release: Availability of the Q1 2026 aide-mémoire
3/24
02:00 am
sny
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
Low
Report
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
3/23
08:31 am
sny
Earendil Labs lands $787m to fund biologics development push [Yahoo! Finance]
Low
Report
Earendil Labs lands $787m to fund biologics development push [Yahoo! Finance]
3/23
08:11 am
sny
Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment [Yahoo! Finance]
Low
Report
Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment [Yahoo! Finance]
3/23
07:09 am
sny
Kali Therapeutics Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Tri-Specific T-Cell Engager for Autoimmune Diseases [Yahoo! Finance]
Low
Report
Kali Therapeutics Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Tri-Specific T-Cell Engager for Autoimmune Diseases [Yahoo! Finance]
3/23
12:51 am
sny
Sanofi Deepens Mirecule And Earendil Ties To Shape Rare Disease Future [Yahoo! Finance]
Low
Report
Sanofi Deepens Mirecule And Earendil Ties To Shape Rare Disease Future [Yahoo! Finance]
3/21
07:13 am
sny
Sanofi (SNY) was upgraded by Sanford C. Bernstein to "strong-buy".
Low
Report
Sanofi (SNY) was upgraded by Sanford C. Bernstein to "strong-buy".
3/20
07:57 am
sny
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development [Yahoo! Finance]
Low
Report
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development [Yahoo! Finance]
3/19
01:13 pm
sny
Generate Biomedicines IPO Turns Heads [Yahoo! Finance]
Low
Report
Generate Biomedicines IPO Turns Heads [Yahoo! Finance]
3/19
07:32 am
sny
Dupixent's Impact On Sanofi: A Quantitative Projection Of Its Revenue [Seeking Alpha]
Low
Report
Dupixent's Impact On Sanofi: A Quantitative Projection Of Its Revenue [Seeking Alpha]
3/18
07:37 am
sny
Mirecule Expands Strategic FSHD Collaboration with Sanofi [Yahoo! Finance]
Low
Report
Mirecule Expands Strategic FSHD Collaboration with Sanofi [Yahoo! Finance]
3/18
04:11 am
sny
?????????????? - ??????????????????2026-2035? [CNET News]
Low
Report
?????????????? - ??????????????????2026-2035? [CNET News]
3/18
03:14 am
sny
Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report [Yahoo! Finance]
Low
Report
Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report [Yahoo! Finance]
3/18
02:14 am
sny
Press Release: Sanofi's venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease [Yahoo! Finance]
Low
Report
Press Release: Sanofi's venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease [Yahoo! Finance]
3/18
02:00 am
sny
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
Low
Report
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease